Page last updated: 2024-10-25

deferoxamine and A-Thalassemia

deferoxamine has been researched along with A-Thalassemia in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gringras, P1
Wonke, B1
Old, J1
Fitches, A1
Valler, D1
Kuan, AM1
Hoffbrand, V1
Webster, BH1
Lammi, AT1

Reviews

1 review available for deferoxamine and A-Thalassemia

ArticleYear
Thalassaemia and other haemoglobinopathies in general practice.
    Australian family physician, 1994, Volume: 23, Issue:8

    Topics: Adult; alpha-Thalassemia; beta-Thalassemia; Bone Marrow Transplantation; Carrier State; Chelation Th

1994

Other Studies

1 other study available for deferoxamine and A-Thalassemia

ArticleYear
Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia.
    Archives of disease in childhood, 1994, Volume: 70, Issue:1

    Topics: Adolescent; Adult; alpha-Thalassemia; beta-Thalassemia; Blood Transfusion; Blotting, Southern; Defer

1994